163 related articles for article (PubMed ID: 23443411)
1. MADD promotes the survival of human lung adenocarcinoma cells by inhibiting apoptosis.
Bi W; Wei Y; Wu J; Sun G; Guo Y; Zhang Q; Dong L
Oncol Rep; 2013 Apr; 29(4):1533-9. PubMed ID: 23443411
[TBL] [Abstract][Full Text] [Related]
2. [Expression of MADD in lung adenocarcinoma tissues and its effects on proliferation and apoptosis of lung adenocarcinoma A549 cells].
Wei YP; Wu JX; Guo YF; Sun GY; Zhang Q; Bi WX; Dong L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Apr; 28(4):354-7. PubMed ID: 22482404
[TBL] [Abstract][Full Text] [Related]
3. MADD Expression in Lung Adenocarcinoma and its Impact on Proliferation and Apoptosis of Lung Adenocarcinoma Cells.
Ye B; Zhong F; Yu G; Lou H; Hu J
Comb Chem High Throughput Screen; 2019; 22(3):207-215. PubMed ID: 30947659
[TBL] [Abstract][Full Text] [Related]
4. Down-modulation of expression, or dephosphorylation, of IG20/MADD in tumor necrosis factor-related apoptosis-inducing ligand-resistant thyroid cancer cells makes them susceptible to treatment with this ligand.
Li LC; Jayarama S; Pilli T; Qian L; Pacini F; Prabhakar BS
Thyroid; 2013 Jan; 23(1):70-8. PubMed ID: 22998497
[TBL] [Abstract][Full Text] [Related]
5. TRAIL suppresses human breast cancer cell migration via MADD/CXCR7.
Wang R; Li JC
Asian Pac J Cancer Prev; 2015; 16(7):2751-6. PubMed ID: 25854358
[TBL] [Abstract][Full Text] [Related]
6. MADD knock-down enhances doxorubicin and TRAIL induced apoptosis in breast cancer cells.
Turner A; Li LC; Pilli T; Qian L; Wiley EL; Setty S; Christov K; Ganesh L; Maker AV; Li P; Kanteti P; Das Gupta TK; Prabhakar BS
PLoS One; 2013; 8(2):e56817. PubMed ID: 23457619
[TBL] [Abstract][Full Text] [Related]
7. Effects of TGF-β signaling blockade on human A549 lung adenocarcinoma cell lines.
Xu CC; Wu LM; Sun W; Zhang N; Chen WS; Fu XN
Mol Med Rep; 2011; 4(5):1007-15. PubMed ID: 21725601
[TBL] [Abstract][Full Text] [Related]
8. MADD silencing enhances anti-tumor activity of TRAIL in anaplastic thyroid cancer.
Saini S; Sripada L; Tulla K; Qiao G; Kunda N; Maker AV; Prabhakar BS
Endocr Relat Cancer; 2019 Jun; 26(6):551-563. PubMed ID: 30999276
[TBL] [Abstract][Full Text] [Related]
9. MADD/DENN splice variant of the IG20 gene is a negative regulator of caspase-8 activation. Knockdown enhances TRAIL-induced apoptosis of cancer cells.
Mulherkar N; Prasad KV; Prabhakar BS
J Biol Chem; 2007 Apr; 282(16):11715-21. PubMed ID: 17314102
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of RBM5 induces autophagy in human lung adenocarcinoma cells.
Su Z; Wang K; Li R; Yin J; Hao Y; Lv X; Li J; Zhao L; Du Y; Li P; Zhang J
World J Surg Oncol; 2016 Feb; 14():57. PubMed ID: 26923134
[TBL] [Abstract][Full Text] [Related]
11. MADD is a downstream target of PTEN in triggering apoptosis.
Jayarama S; Li LC; Ganesh L; Mardi D; Kanteti P; Hay N; Li P; Prabhakar BS
J Cell Biochem; 2014 Feb; 115(2):261-70. PubMed ID: 24038283
[TBL] [Abstract][Full Text] [Related]
12. Beclin 1 promotes apoptosis and decreases invasion by upregulating the expression of ECRG4 in A549 human lung adenocarcinoma cells.
Wang W; Fan H; Li X; Wu G; Zhao W; Zhang G; Zhao G; Li L
Mol Med Rep; 2016 Jul; 14(1):355-60. PubMed ID: 27175789
[TBL] [Abstract][Full Text] [Related]
13. The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.
Dong S; Qu X; Li W; Zhong X; Li P; Yang S; Chen X; Shao M; Zhang L
J Hematol Oncol; 2015 Apr; 8():43. PubMed ID: 25925741
[TBL] [Abstract][Full Text] [Related]
14. MADD, a splice variant of IG20, is indispensable for MAPK activation and protection against apoptosis upon tumor necrosis factor-alpha treatment.
Kurada BRVVSN; Li LC; Mulherkar N; Subramanian M; Prasad KV; Prabhakar BS
J Biol Chem; 2009 May; 284(20):13533-13541. PubMed ID: 19289468
[TBL] [Abstract][Full Text] [Related]
15. Small interference RNA targeting tissue factor inhibits human lung adenocarcinoma growth in vitro and in vivo.
Xu C; Gui Q; Chen W; Wu L; Sun W; Zhang N; Xu Q; Wang J; Fu X
J Exp Clin Cancer Res; 2011 May; 30(1):63. PubMed ID: 21619686
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism of thymosin beta 10 inhibiting the apoptosis
and prompting proliferation in A549 cells].
Li Z; Qu L; Zhong H; Xu K; Qiu X
Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):783-8. PubMed ID: 25404268
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of livin expression suppresses cell proliferation and enhances chemosensitivity to cisplatin in human lung adenocarcinoma cells.
Zhuang L; Shen LD; Li K; Yang RX; Zhang QY; Chen Y; Gao CL; Dong C; Bi Q; Tao JN; Wang XN; Tian Q
Mol Med Rep; 2015 Jul; 12(1):547-52. PubMed ID: 25695324
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of miR-522 suppresses proliferation and metastasis of non-small cell lung cancer cells by directly targeting DENN/MADD domain containing 2D.
Zhang T; Hu Y; Ju J; Hou L; Li Z; Xiao D; Li Y; Yao J; Wang C; Zhang Y; Zhang L
Sci Rep; 2016 Jan; 6():19346. PubMed ID: 26783084
[TBL] [Abstract][Full Text] [Related]
19. MADD/DENN splice variant of the IG20 gene is necessary and sufficient for cancer cell survival.
Mulherkar N; Ramaswamy M; Mordi DC; Prabhakar BS
Oncogene; 2006 Oct; 25(47):6252-61. PubMed ID: 16682944
[TBL] [Abstract][Full Text] [Related]
20. The tumor suppressor gene RBM5 inhibits lung adenocarcinoma cell growth and induces apoptosis.
Shao C; Zhao L; Wang K; Xu W; Zhang J; Yang B
World J Surg Oncol; 2012 Aug; 10():160. PubMed ID: 22866867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]